Additionally, serum IL-13 levels and IL-13-related cytokine ratios (e.g., IFN-γ/IL-13, IL-17A/IL-13) have been associated with clinical responses to biologic therapies in psoriasis [15]. This evidence concerns the gene IL17A and psoriasis.